ArticleBMJ open2026

Clinical benefit, price and epidemiology of orphan drugs approved in China: a cross-sectional analysis of orphan drug policy (ODP) in China.

Jing Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.